TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, has made a significant minority investment in AnovoRx Holdings (Anovo), a provider of specialty pharmacy services and customised treatment and support programs that address the unique needs of patients with certain complex and chronic diseases.
TPG is a global healthcare investor and has made numerous growth stage investments across the sector. Those transactions include BGB Group, Implantable Provider Group, Pharmeasy, Stelis Biopharma, and Vasaragen.
Read more/Source: Private Equity Wire
Can't stop reading? This and all news articles are property of their creators, many are not owned or provided by Private Equity Insider. As an event organizer and community platform, we curate content from reliable sources for your suggested reading, and advise you to read the full articles from the referenced authors and sources.